Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria.
Alexandre TR
,
Lima ML
,
Galuppo MK
,
Mesquita JT
,
do Nascimento MA
,
Dos Santos AL
,
Sartorelli P
,
Pimenta DC
,
Tempone AG
.
???displayArticle.abstract???
BACKGROUND: Major drawbacks of the available treatment against Chagas disease (American trypanosomiasis) include its toxicity and therapeutic inefficiency in the chronic phase of the infection, which makes it a concern among neglected diseases. Therefore, the discovery of alternative drugs for treating chronic Chagas disease requires immediate action. In this work, we evaluated the mushroom Pleurotus salmoneostramineus in the search for potential antiparasitic compounds.
METHODS: Fruit bodies of the basidiomycete Pleurotus salmoneostramineus were triturated and submitted to organic solvent extraction. After liquid-liquid partition of the crude extract, three fractions were obtained and the bioguided fractionation study was conducted to isolate the active metabolites. The elucidation of the chemical structure was performed using GC-MS and NMR techniques. The biological assays for antiparasitic activity were carried out using trypomastigotes of Trypanosoma cruzi and murine macrophages for mammalian cytotoxicity. The mechanism of action of the isolated compound used different fluorescent probes to evaluate the plasma membrane permeability, the potential of the mitochondrial membrane and the intracellular levels of reactive oxygen species (ROS).
RESULTS: The most abundant fraction showing the antiparasitic activity was isolated and chemically elucidated, confirming the presence of ergosterol. It showed anti-Trypanosoma cruzi activity against trypomastigotes, with an IC50 value of 51.3 μg/mL. The compound demonstrated no cytotoxicity against mammalian cells to the maximal tested concentration of 200 μg/mL. The mechanism of action of ergosterol in Trypanosoma cruzi trypomastigotes resulted in permeabilization of the plasma membrane, as well as depolarization of mitochondrial membrane potential, leading to parasite death. Nevertheless, no increase in ROS levels could be observed, suggesting damages to plasma membrane rather than an induction of oxidative stress in the parasite.
CONCLUSIONS: The selection of naturally antiparasitic secondary metabolites in basidiomycetes, such as ergosterol, may provide potential scaffolds for drug design studies against neglected diseases.
Barrero,
Phycomysterols and other sterols from the fungus Phycomyces blakesleeanus.
1998, Pubmed
Barrero,
Phycomysterols and other sterols from the fungus Phycomyces blakesleeanus.
1998,
Pubmed
Bestetti,
Did death hinder the process of justice? Carlos Chagas and the Nobel Prize of 1935.
2011,
Pubmed
Bettiol,
Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening.
2009,
Pubmed
Borges,
Extracellular polysaccharide production by a strain of Pleurotus djamor isolated in the south of Brazil and antitumor activity on Sarcoma 180.
2013,
Pubmed
Boscardin,
Chagas' disease: an update on immune mechanisms and therapeutic strategies.
2010,
Pubmed
Braga,
Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi.
2004,
Pubmed
Brilhante,
In vitro antifungal activity of miltefosine and levamisole: their impact on ergosterol biosynthesis and cell permeability of dimorphic fungi.
2015,
Pubmed
Chatelain,
Translational challenges of animal models in Chagas disease drug development: a review.
2015,
Pubmed
Chowdhury,
Screening of antimicrobial, antioxidant properties and bioactive compounds of some edible mushrooms cultivated in Bangladesh.
2015,
Pubmed
Croft,
Chemotherapy of trypanosomiases and leishmaniasis.
2005,
Pubmed
De Souza,
Trypanosoma cruzi-Host Cell Interaction.
2014,
Pubmed
Duschak,
An insight on targets and patented drugs for chemotherapy of Chagas disease.
2007,
Pubmed
Elsayed,
Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications.
2014,
Pubmed
Francisco,
Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.
2015,
Pubmed
Galli,
Mass spectrometric investigations of some unsaturated sterols biosynthetically related to cholesterol.
1967,
Pubmed
Ginger,
Utilization of leucine and acetate as carbon sources for sterol and fatty acid biosynthesis by Old and New World Leishmania species, Endotrypanum monterogeii and Trypanosoma cruzi.
2000,
Pubmed
Lai,
Leishmanicidal and anticandidal activity of constituents of Indian edible mushroom Astraeus hygrometricus.
2012,
Pubmed
Lazardi,
Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
1990,
Pubmed
Lazarin-Bidóia,
Further evidence of the trypanocidal action of eupomatenoid-5: confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in trypanothione reductase activity.
2013,
Pubmed
Lo,
Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms.
2012,
Pubmed
Mathur,
Elevated ergosterol protects Leishmania parasites against antimony-generated stress.
2015,
Pubmed
Menna-Barreto,
The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics.
2014,
Pubmed
Mercer,
Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds.
2007,
Pubmed
Meshnick,
Artemisinin: mechanisms of action, resistance and toxicity.
2002,
Pubmed
Mikus,
A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.
2000,
Pubmed
Moraes,
Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.
2014,
Pubmed
Nganso,
Antitrypanosomal and cytotoxic activities of 22-Hydroxyclerosterol, a new sterol from Allexis cauliflora (Violaceae).
2011,
Pubmed
Pereira,
Challenges and perspectives of Chagas disease: a review.
2013,
Pubmed
Pinto,
Antileishmanial and antitrypanosomal activity of the cutaneous secretion of Siphonops annulatus.
2014,
Pubmed
Planer,
Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.
2014,
Pubmed
Quiñones,
The glycosome membrane of Trypanosoma cruzi epimastigotes: protein and lipid composition.
2004,
Pubmed
Ramos-Ligonio,
Trypanocidal activity of ergosterol peroxide from Pleurotus ostreatus.
2012,
Pubmed
Ramírez-Macías,
In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruzi.
2012,
Pubmed
Rea,
Soulamarin isolated from Calophyllum brasiliense (Clusiaceae) induces plasma membrane permeabilization of Trypanosoma cruzi and mytochondrial dysfunction.
2013,
Pubmed
,
Echinobase
Roberts,
Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa.
2003,
Pubmed
Rodrigues,
The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin-permeabilization.
2001,
Pubmed
Romanha,
In vitro and in vivo experimental models for drug screening and development for Chagas disease.
2010,
Pubmed
Rosa,
Cytotoxic, immunosuppressive, trypanocidal and antileishmanial activities of Basidiomycota fungi present in Atlantic Rainforest in Brazil.
2009,
Pubmed
Santos,
Anti-parasitic Guanidine and Pyrimidine Alkaloids from the Marine Sponge Monanchora arbuscula.
2015,
Pubmed
Simões-Silva,
Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi.
2016,
Pubmed
Soeiro,
In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
2013,
Pubmed
Souza-Fagundes,
In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy.
2010,
Pubmed
Tempone,
Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad Rhinella jimi parotoid macrogland secretion.
2008,
Pubmed
Urbina,
Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
1991,
Pubmed
Usami,
Chemical composition and aroma evaluation of volatile oils from edible mushrooms (Pleurotus salmoneostramineus and Pleurotus sajor-caju).
2014,
Pubmed
Verma,
CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani.
2011,
Pubmed
Viegelmann,
Isolation and identification of antitrypanosomal and antimycobacterial active steroids from the sponge Haliclona simulans.
2014,
Pubmed
Wu,
Isolation and characterization of a novel ribonuclease from the pink oyster mushroom Pleurotus djamor.
2010,
Pubmed
Yang,
Quantifying membrane permeability of amphotericin B ion channels in single living cells.
2013,
Pubmed
Yoon,
Hypolipidemic and antiatherogenesis effect of culinary-medicinal pink oyster mushroom, Pleurotus salmoneostramineus L. Vass. (higher Basidiomycetes), in hypercholesterolemic rats.
2012,
Pubmed
de Góes Costa,
Acute Chagas Disease in the Brazilian Amazon: Epidemiological and clinical features.
2017,
Pubmed
de-Castro,
Differential effect of amphotericin B on the three evolutive stages of Trypanosoma cruzi and on the host cell-parasite interaction.
1993,
Pubmed